MR
Spectroscopy of White Matter Disease and Degeneration Room 204
A/B Chairs: Thomas Ernst and Norbert Schuff |
11:00 42. Neuronal Damage in T1 Hypointense Multiple Sclerosis Lesions Demonstrated In Vivo Using 1H-MRS, M.A.A. van Walderveen, F. Barkhof, P.J.W. Pouwels, R.A. van Schijndel, C.H. Polman and J.A. Castelijns, Dutch MR Center for MS-Research and University Hospital, Vrije Universiteit, Amsterdam, the Netherlands. |
11:12 43. Quantitative Proton MRS of Cerebral Multiple Sclerosis Lesions: Regression Analysis of Metabolite Concentrations, G. Helms, L. Stawiarz, P. Kivisäkk, S. Fredrikson, J. Hillert and H. Link, Karolinska Institutet, Stockholm, Sweden. |
11:24 44. 3D 1H MRS of "Normal Appearing White Matter" in Patients with Relapsing-Remitting Multiple Sclerosis, B.S.Y. Li, A.K. Viswanathan, P. Patriotis, L.J. Manonn, D. Kolson, R.I. Grossman and O. Gonen, Fox Chase Cancer Center and University of Pennsylvania Medical Center, Philadelphia, PA, USA. |
11:36 45. Relation of Brain Metabolite Concentrations to Cognitive Functions in Alzheimer Disease: A Quantitative In Vivo 1H MRS Study, W. Huang, G.E. Alexander, L. Chang, B. Levine, J. Szczepanik, S.I. Rapoport and M.B. Schapiro, State University of New York, Stony Brook, NY, USA and National Institute on Aging, Bethesda, MD, USA. |
11:48 46. Reference Normalized Quantification of Cerebral Metabolites in Alzheimer's Patients Using an External Standard in Proton Magnetic Resonance Spectroscopic Imaging, X. Yu, M.F. Danish, K.R.R. Krishnan and H.C. Charles, Duke University Medical Center, Durham, NC, USA. |
12:00 47. 1H MRS in Normal Aging, Pre-Symptomatic and Probable Alzheimer's Disease, K. Kantarci, R.C. Petersen, Y.C. Xu, N.G. Campeau and C.R. Jack Jr., Mayo Clinic, Rochester, MN, USA. |
12:12 48. Grade-Dependent Concentration Variation of Cerebral Metabolites in X-Linked Adrenoleukodystrophy: 1H MR Spectroscopy, J-J. Seo, H-K. Kang, Y-H. Kim, Y-Y. Jeong, J-G. Park, S-J. Park, H-J. Kim and G-W. Jeong, Chonnam National University, Kwang-Ju, Korea. |
12:24 49. Metabolic, Structural and Neuropsychological Deficits in Mitochondrial Encephalopathies Assessed by 1H MRSI, MRI and Neuropsychological Testing, D.C. Shungu, M. Sano, W.S. Millar, Y. Polanco, P. Kaufmann, R.L. DeLaPaz, S. DiMauro and D.C. De Vivo, Columbia University, New York, NY, USA. |
12:36 50. Clinical Outcome and Immune Response to Neurotransplantation, B.D. Ross, O. Kopyov, S. Bluml and J. Tan, Huntington Medical Research Institutes, Pasadena, CA, USA; Rudi Schulte Research Institute, Santa Barbara, CA, USA and Good Samaritan Hospital, CA, USA. |
12:48 51. Long-Term MRS Studies on Impact of Surgical Shunting in Hydrocephalic Patients, S. Bluml, J. Tan, J.G. McComb and B.D. Ross, Huntington Medical Research Institutes, Pasadena, CA, USA; Rudi Schulte Research Institute, Santa Barbara, CA, USA and Children's Hospital of Los Angeles, CA, USA. |